Analysis of used disinfectants and antiseptics correlated with the occurrence of nosocomial infections – Clinical hospital Stip, Republic of Macedonia in period of 2007 – 2011 by Petkovska, Sofija & Gjorgjeska, Biljana
Analysis of used disinfectants and antiseptics correlated with the occurrence of nosocomial 
infections – Clinical hospital Stip, Republic of Macedonia in period of 2007 – 2011 
Sofija Petkovska1, Biljana Gjorgjeska2 
1Univesity Goce Delcev, Fakulty of medical sciences 
sofija.petkovska@ugd.edu.mk 
2Univesity Goce Delcev, Fakulty of medical sciences 
biljana.gorgeska@ugd.edu.mk 
 
Abstract:  
Intra-hospital or nosocomial hospital infections are caused by microorganisms acquired during the hospitalization 
of the patient, and clinically are manifested from 48 to 72 hours after admission at earliest. The procedures for 
disinfection and the type and quantity of disinfectants used are directly related to the effects.   
The control of intra-hospital infections is performed by intra-hospital infections Commission which is responsible 
for taking swabs of sediments and air for proving none/presence of bacteria, as well as taking measures if 
contamination occurs and timely detection of intra-hospital infections.   
This research’s aim is to review and select appropriate ways in order to prevent intra-hospital infections. Statistical 
processing of data received from Clinical Centre in Stip, Republic of Macedonia in the period 2009 to 2013 gives a 
complete insight into the connection between the use of disinfectants with occurrence and absence of intra-hospital 
infections.  
Prevention of intra-hospital infections is possible only by implementing standard processes and procedures that 
enable optimal use of properly selected disinfectants in all departments in hospitals. Special attention should be 
given to the procedures for preparing and delivering food to patients and the procedures for disinfection and control 
of space and food preparation, store and distribute food.   
1. Introduction 
Nosocomial infections represent worry in great proportions for both staff and patients. Therefore, they give great 
emphasis on proper prevention which includes primarily the optimal use of disinfectants and antiseptics, and regular 
microbiological testing and controls. Antiseptics and disinfectants are widely used in hospitals and other medical 
facilities in different topical application and hard surfaces. The composition of disinfectants into a wide variety of 
active chemical agents (biocides) applied over hundreds of years and according to the chemical composition 
represent alcohols, phenols, iodine and chlorine compounds. Most of these active substances show a broad spectrum 
of antimicrobial activity, but little is known about the mode of action of these agents compared with the action of 
antibiotics. In general, biocides have a broader spectrum of action than antibiotics. While antibiotics tend to target 
specific intracellular targets, biocides have different, multiple goals. The widespread use of these products raises 
doubts among many scientists and researchers to the development of antibiotic resistance, especially cross-resistance 
with the question whether resistance to antibiotics is caused by the use of antiseptics and disinfectants. [1]  
Mechanical cleaning before application of disinfectants is essential. Mechanisms of antibacterial disinfectants are 
summarized in several large critical reports worldwide. For example, alcohols show rapid action and broad spectrum 
of antimicrobial activity through denaturation of proteins, but do not act sporicidal. Aldehydes act by linking the 
amino groups of proteins, RNA and DNA. Oxidizing agents such as peroxides and halogens oxidize proteins thiol 
groups while surface active agents mainly act on the cytoplasmic membrane of the bacterial cell or plasma 
membrane of the yeasts. Phenols generally destroy the membrane.  
For the use of biocides as chemicals is important to note that many of these biocides can be used independently or in 
combination with various other products that differ significantly in their activity. Antimicrobial activity may be 
influenced by many factors that can arise from the formulation, the synergistic activity, temperature, dilution and 
evaporation. Biocide is a general term used to describe a chemical agent, usually with a broad spectrum of activity, 
which inactivates microorganisms. Biocidal activity is within the antimicrobial activity, but depending on the 
conditions you have and "The State" activity that is directed to agents that inhibit growth (bacteriostatic, fungistatic 
and sporostatic activity), and also "cidal" activity directed agents to completely destroy all microorganisms present 
(bactericidal, sporicidal, fungicidal).[2] 
Regardless of the type of organism that is present there is always a common sequence of events. Previous interaction 
means disinfecting or antiseptic to the cell surface followed by penetration into the cell or simply target cell activity. 
The nature and composition of the surfaces vary from one cell to another. But external factors or environmental 
factors can also affect the activity of antiseptics and disinfectants. The interaction with the bacterial cell surface can 
have a significant impact on the sustainability of the effect of the used chemicals, but insignificant stake is the fact 
that most antimicrobial agents act intracellular. The interior of the bacterial cell can thus have a significant impact 
on the general, overall durability of the bacterial cell or a different sensitivity to disinfectants and antiseptics, which 
is quite disappointing how little is known and there is evidence to the effect and impact of funds disinfectants and 
antiseptics to different types of bacterial cells. However, the potentiating of the action of certain disinfectants and 
antiseptics can be achieved by using different additives that significantly increase their potency. 
1.1. Hospital-acquired infection (nosocomial infection) 
A great number of studies around the world show and prove that hospital infections are a major cause of morbidity 
and mortality. High frequency of hospital infections is evidence of poor quality of health services and lead to 
unforeseen and unavoidable expenses. Many factors contribute to the incidence of hospital infections: hospitalized 
patients are often immuno-compromised. Often, subjected to invasive treatments and examinations and practical 
patient care in the hospital environment can facilitate the transmission of microorganisms among patients. The 
intensive use of antibiotics promotes the same resistant. Advances in the prevention of hospital infections is steadily 
increasing, and studies of the proper application and use of disinfectants, depending on their purpose and structure 
are constantly emerging. [3]  
The incidence of nosocomial hospital infections is still conducted in 1966 a study on the occurrence of infection 
caused by the Staphylococcus Aureus. The research has been done on different types of staphylococci responsible 
for the occurrence of cross infections in large hospitals between 1961 and 1966. Research has shown that infections 
are caused by three different types of staphylococcal to later identify and prove new species resistant to antibiotics. 
Two main groups of staphylococci were isolated species responsible for most cases of cross-infection in two 
hospitals. Species resistant to antibiotics are proven epidemiological types. It was proved that the typical group 
which causes infection is the main cause of infections in patients with open wounds and surgical areas with skin 
ulceration. The correlation was established between species resistant to antibiotics and similar vines of the two 
different types of bacteria. This research has provided result in increased guidance for improving the control of the 
occurrence of infections in hospitals and taking appropriate measures to prevent further spread. [4]  
National surveillance for infection control departments for coronary artery bypass grafting in Norway started 
operating in 2005. A study designed to measure and establish baseline incidence of the occurrence of infections in 
these departments, was conducted to describe the characteristics of patients, procedures and to identify possible risks 
of infection. [5]  
Protection and prevention of nosocomial infections as patients and staff brings important for every healthcare 
institution. Study on integrated mechanism for protection of patients was conducted during 2001 and explains all 
procedures, methods, protocols and aspects for better patient care and also includes protection against hospital 
infections. The same study develops system with integrated mechanism, a scheme for patient protection and 
infection control staff deals with four main issues  
- What are the requirements for the control of infection in terms of performance requirements of the patients  
- What are the best ways to achieve these results?  
- Who should be responsible for the results?  
- Are there guidelines based on evidence that should be incorporated into protocols for protection [6]  
In order to comprehensively monitoring hospital infections in health care, patients are asked to monitor the studies 
about the point of prevalence of hospital infections. Monitoring of point prevalence was first established in Canada 
in University Hospital to establish baseline data about the occurrence of hospital acquired infections. This approach 
attempts to overcome the multitude of barriers, to practice universal surveillance potential and to achieve 
quantitative estimate of the number of hospital infections that occur. The study indicates that a reasonable alternative 
to this method is the development of a method that will rely on the concentrated control of microbial cultures.[7] 
A 2008 study suggests very few published reports on key focus of hospital teams of hospital infection control. 
Evidence from research suggests a multidisciplinary team based at the hospital, which should have a strategic 
approach and commitment to control hospital infections in all clinical areas. The structure and operation of teams 
includes supervision and differs from hospital to hospital from clinic to clinic depending on their needs. High quality 
and efficiency are crucial to reduce the risk of nosocomial infections, and as a result, and reduce mortality and 
morbidity in hospitals. [8]  
The basic tool of a study indicates that the data collection is necessary and to be used in order to advance a sweeping 
operation to improve the performance of a health institution. Teams of professionals constantly have access to all 
data for the possible occurrence of hospital infections. By simply collecting, collating and analysing all available 
data can reach effective conclusions. A simple description of the data can lead to many important facts that will be 
helpful in providing better protection and guidance on the specific procedures for protection. The study indicates 
that the primary should beware teams professionals involved in the protection against infection  
- What data on the occurrence of hospital infections are routinely available daily  
- Is this sufficient data can be gathered to describe the infection occurred during testing and epidemiological 
research  
- How effective is the data used  
- Is different, not daily presentation of the data will have a different effect  
- What are the key priorities for the control of hospital infections in a healthcare institution and which data, methods 
and means of presenting the data would be best to improve the control of hospital infections [9]  
The literature provides many examples and explanations for microbial resistance to disinfectants. This can be proved 
either by laboratory experiments using elevated levels of biocides to choose the most appropriate, depending on the 
bacterial population or by examining biocidal solutions the presence of resistant microbial strains. Gram-negative 
bacilli are the most common isolates from this type of evaluation biocidal activity. This may be due to a 
combination of factors including changes in the permeability of the outer membrane which in turn is due to the 
change in the diameter of the pores. [10]  
Most disinfectants and antiseptics used in hospitals are prepared as solutions in hospital pharmacies from where they 
are distributed to all hospital departments. Research shows that contamination is possible during their manufacture. 
The level of contamination of some bacterial species ranges from 102 to 108 bacterial colonies formed per millilitre 
disinfectant / antiseptic to the possibility of achieving the infectious dose at the site of application. Epidemiological 
reports indicate many hospitals which often use contaminated disinfectants and antiseptics applied directly to the 
skin of patients, and are often used for decontaminations of instruments and diagnostic devices for treatment of 
patients. The data suggests many resistant bacteria isolated from disinfectants and antiseptics.[11] 
2.0 Goals 
The purpose of this paper is to show the connection between the used disinfectants and antiseptics in the Clinical 
Centre - Stip for five years, from 2007 to 2011 and the possible occurrence of hospital infections.  
3.0 Materials and methods  
The data used for antiseptics and disinfectants are derived from  
• Annual Evidence List of Clinical Centre - Stip. They are processed separately for each ward.  
• Annual reports of the Centre for Public Health Stip - Epidemiologic Service.  
The statistical analysis of the data analysed is the use of disinfectants and antiseptics annually each ward separately 
in Clinical Centre - Stip compared with the results of the microbiological analysis carried out in the Centre for 
Public Health - Stip. It is estimated the possible occurrence of hospital infections over a period of five years. The 
processed data provide the following results.  
4.0 Results  
The total amount of the most commonly used antiseptics and disinfectants of all departments in the Clinical Hospital 
- Stip in 2007 and 2011 is shown in Table 1.  
Table 1: Total amount of commonly used antiseptics and disinfectants of all departments in the Clinical Hospital - Stip in 2007 to 
2011 
 
 
 
 
 Graph No. 1 - Consumption of commonly used antiseptics and disinfectants in liquid form during the years from 2007 to 2011 
                
In the period from 2007 to 2011 used antiseptics and disinfectants in liquid form, in 2007 spent the greatest amount 
of Aethanol (294 liters), and the smallest amount Deconex 54 sporcide (3 liters). In 2008 spent the greatest amount 
of Aethanol (930 liters), and the smallest amount Deconex gastro (5 liters). In 2009 spent major amounts of 
Aethanol (377 liters), and the smallest amount Hidrogen conc. (22 liters). 2010 spent major amounts of Betadine 
10% (210 liters), and the smallest amount Deconex 50 AF + FF (12,5 liters). In 2011 spent major amounts of 
Betadine 10% (315 liters), and the smallest amount Acidi Borici (13 liters). 
Graph No. 2 - Consumption of commonly used antiseptics and disinfectants in solid form during the years from 2007 to 2011 
 
In the period from 2007 to 2011 of disinfectant and antiseptics used in the solid state, in 2007 spent the greatest 
amount of Formaldechide tablets (1025), and the smallest amount of Jodofrm PLV (0,5 kg). In 2008 spent major 
amounts of Formaldechide tablets (1650), and the smallest amount Hidreks surgic scrab (0,5 kg). In 2009 spent 
major amounts of Medicarine Nat. (16800 tablets), and the lowest amount Sekusept aktiv (4 kg). In 2010 spent 
major amounts of Medicarine Nat (10800 tableti), and the smallest amount Sekusept aktiv (4,5 kg). In 2011 spent 
major amounts of Suma D4 (13020 tableti), and the smallest amount Jodoform PLV (0,5kg) 
The total amount of commonly used antiseptics and disinfectants in hospital departments in Clinical hospital - Stip 
in the period from 2007 to 2011 is shown below. 
Graph No. 3 - Quantities of antiseptics and disinfectant spent in Gynaecology department in the Clinical Hospital - Stip in period 
of 2007 and 2011 
 
Gynecology department in the period from 2007 to 2011 spent major amounts of antiseptics and disinfectants in 
liquid form: Betadine 10% (total 94.8 liters), and the smallest amount of Decosept (1 liter). 2007 consumed the 
greatest amount of Betadine 10% (7.5 liters), and the lowest amount of Betadine 7,5% (0,5 liters) while Aethanol 
conc., Hidrogen conc., Incidin foam. and Deconex gastro were not used. 2008 spent major amounts of Betadine 10% 
(50 liters), and the lowest amount of Deconex 50 AF + FF (5 liters), Formaldehid 35% (5 liters), while Aethanol 
conc., Betadine 7,5%, Hidrogen conc. Incidin foam., Deconex gastro and Decosept are not used at all. In 2009 are 
spent most of Betadine 10% (8.5 liters), the lowest spent amount is Aethanol conc. (0.25 liters) and Hidrogen conc. 
(0.25 liters) while Deconex 50 AF + FF and Decosept are not uset at all. In 2010 spent the least amount of Aethanol 
(0,05 liters) and Hidrogen conc. (0.05 liters), while Betadine 7,5%, Deconex 50 AF + FF, Deconex gastro, 
Formaldehid 35% and Decosept are not used at all. In 2011 spent major amounts of Betadine 10% (13.8 liters), and 
minor amounts of Aethanol conc. (0.5 liters), Betadine 7,5% (0,5 liters) and Hidrogen conc. (0.5 liters) while 
Deconex gastro, Formaldehid 35% Decosept are not used 
 
 
. 
Graph No. 4 - Quantities of antiseptics and disinfectant spent in Intensive care in the Clinical Hospital - Stip in period of 2007 
and 2011 
 
The Intensive Care unit spent largest amounts of Ecosal (total of 39.89 liters), and the smallest amount of 
Formaldehide 35% (0.15 liters). In 2007 the largest amount is spent of Aethanol conc (4,4 liters), and the lowest 
Ecosal (0,49 liters). Formaldehide 35%, Incidin foam are not used. In 2008 the largest amount is spent of Aethanol 
conc. (4,23 liters), and the lowest Ecosal (1,41 liter). Formaldehide 35%, Incidin foam are not used. In 2009 
consumed the greatest amount of Ecosal (37 liters) and and the lowest Formaldehide 355 (0.15 liters). In 2011 was 
used only Ecosal and spent total 0.51 liters. 
Graph No. 5 - Quantities of antiseptics and disinfectant spent in Internal medical department in the Clinical Hospital - Stip in 
period of 2007 and 2011 
 
In the Internal medical department used antiseptics and disinfectants are only Aethanol conc. and Ecosal. In largest 
quantities  is used Ecosal (total 148.5 liters) and smaller Aethanol conc. (3.23 liters). In 2007 and 2008 a greater 
amount is spent of Aethanol conc, in 2009, 2010 and 2011 is more used Ecosal. 
 
Graph No. 6 - Quantities of antiseptics and disinfectant spent in Urology department in the Clinical Hospital - Stip in period of 
2007 and 2011 
 
The Urology department spent major amounts of Decosept (31 liter), and the smallest amount of Incidin foam (total 
of 0.75 liters). In 2007 spent major amounts of Decosept (7 liters), and the smallest amount of Hidrogen conc. (0,28 
liters), while Incidin foam is not used. In 2008 spent major amounts of Deconex 50 AF + FF and Decosept 24 liters, 
the smallest amount of Ecosal (3 liters), while Incidin foam is not used. In 2009 spent major amounts of Betadine 
7,5% (7,5 liters), the smallest amount of Hidrogen conc. (0.6 liters) while Deconex 50 AF + FF and Decosept are 
not used. In 2010 spent major amounts of Aethanol conc. (1.6 liters), the smallest amount of Hidrogen conc. (0,5 
arch), and Betadine 10%, Betadine 7,5%, Decosept, Deconex 50 AF + FF and Incidin foam are not used. In 2011 
spent major amounts of Betadine 7,5%, the lowest amount of Hidrogen conc. (0.2 liters) while Aethanol, Deconex 
50 AF + FF, Decosept and Incidin foam are not used. 
Graph No. 7 - Quantities of antiseptics and disinfectant spent in Otorhinolaryngology department in the Clinical Hospital - Stip in 
period of 2007 and 2011 
 
The otorhinolaryngology department consumed largest amounts of Deconex 50 AF + FF (21 liter), and the lowest 
amount of Formaldehide 35% (total of 2.56 liters). In 2007 spent major amounts of Deconex 50 AF + FF (11 liters), 
and the smallest amount Ecosal (0,26 liters). 2008 spent major amounts of Betadine and 10% Decosept 15 liters, and 
the smallest amount Formaldehid 35% (2 liters). In 2009 spent major amounts of Aethanol conc. (2,1 liter), and the 
smallest amount of Hidrogen conc. (0,45 liters), while Betadine 7,5%, Deconex 50 AF + FF, Decosept and 
Formaldehide 35 % are not used. 2010 spent major amounts of Betadine 10% (2 l), the lowest amount of Hidrogen 
conc. (0,1 liter), and Betadine 7,5%, Deconex 50 AF + FF, Decosept Formaldehid and 35% are not used . In 2011 
spent major amounts of Betadine 10% (1.95 liters), the smallest amount of Hidrogen conc. (0,4 liters), while 
Betadine 7,5%, Deconex 50 AF + FF, Decosept Formaldehid and 35% are not are used. 
The results of microbiological tests on swabs taken in Clinical Hospital Stip implemented at the Center for Public 
Health is shown as a percentage of contaminated and uncontaminated materials by departments and years. 
Table No. 2 - Examined swabs in Clinical Hospital Stip in 2007 
Department 
Uncontaminated 
materials % 
Contaminated  
materials % 
Intensive care 
unit 33% 77% 
Gynecology dep. 87,50% 12,50% 
Surgery dep 66,60% 33,40% 
Pediatrics  36,30% 63,60% 
Dep. for dialysis 100% 0,00% 
Obstetrics dep. 100% 0,00% 
Orthopaedic dep. 23,50% 76,50% 
Kitchen and 
laundry 37,50% 62,50% 
 
Graph No. 8 - Graphic display of swabs examined in Clinical Hospital Stip in 2007 
 
During the 2007 Center for Public Health has conducted 77 hygiene-epidemiological insights in several offices in 
Clinical Hospital Stip and other public and private health organizations in areas where is the greatest opportunity for 
the emergence and spread of hospital infections. The largest proportions of contaminated swabs were examined 
orthopaedic department where the percentage reaches 76.50% in one year. 100% uncontaminated material has been 
tested and proven on dialysis departments and obstetric unit. 
Table No. 3 - Examined swabs in Clinical Hospital Stip in 2008 
Department 
Uncontaminated 
materials % 
Contaminated 
materials % 
Gynecology dep. 84,30% 15,70% 
Surgery dep 78,70% 21,30% 
Orthopaedic dep. 77% 23% 
Anesthesiology dep 50,90% 49,10% 
Dep. for dialysis 88,80% 11,20% 
Pediatrics 74,50% 25,50% 
Other 89,80% 10,20% 
 
Graph No. 9 - Graphic display of swabs examined in Clinical Hospital Stip in 2008 
 
During the 2008 Center for Public Health Stip performed 36 hygiene-epidemiological insights in several offices in 
Clinical Hospital Stip and other public and private health organizations in areas where are the greatest opportunity 
for the emergence and spread of hospital infections. Total examined materials are 570 and 37 were spurious 
according to test for correctness of sterilization. Of these 480 are sterile, and in 90 of them were found present 
bacteria. In fact 15.7% of the materials are contaminated with bacteria. The largest percentages of swabs were 
contaminated at department of Anesthesiology 49.1%, and the lowest percentage of dialysis 11.2%. 
 
 
 
Table No. 4 - Examined swabs in Clinical Hospital Stip in 2009 
Department 
Uncontaminated  
materials % 
Contaminated  
materials % 
Gynecology dep. 63% 37% 
Surgery dep 72,50% 27,50% 
Orthopaedic dep. 59,50% 40,50% 
Anesthesiology dep 72,90% 27,10% 
Dep. for dialysis 73,60% 26,40% 
Pediatrics 72,50% 27,50% 
Other 14,80% 85,20% 
 
Graph No. 10 - Graphic display of swabs examined in Clinical Hospital Stip in 2009 
 
In 2009, were performed 34 hygiene-epidemiological insights in several offices in Clinical Hospital Stip and other 
public and private health organizations in the areas where are the greatest opportunity for emergence and spread of 
hospital infections. Once a month were taken materials for microbiological examinations (sediment air, swabs of 
surfaces and instruments and testing the accuracy of sterilization). Total surveyed 376 materials and 16 spores.  244 
of this were sterile, and in 99 were found present bacteria. In fact 26.3% of the materials are contaminated with 
bakteria. largest percentages of swabs were recorded at the Department of Orthopaedics 40.5% and 26.4% at 
department for dialysis 
 
 
 
 
Table No. 5 - Examined swabs in Clinical Hospital Stip in 2010 
Department 
Uncontaminated  
materials % 
Contaminated  
materials % 
Gynecology dep. 71,80% 28,20% 
Surgery dep 60% 40% 
Orthopaedic dep. 75,40% 24,60% 
Anesthesiology dep 64,90% 35,10% 
Dep. for dialysis 54,90% 45,10% 
Pediatrics 66,20% 33,80% 
Dep. for infectious 
diseases 57,10% 42,90% 
Ophthalmology dep. 80% 20% 
other 75% 25% 
 
Graph No. 11 - Graphic display of swabs examined in Clinical Hospital Stip in 20010 
 
In 2010 epidemiological service of the Center for Public Health conducted 49 hygiene-epidemiological insights in 
Clinical hospital Stip. Total 604 materijals were examined. 436 of these were sterile and at 168 were found present 
bacteria. In fact 27.8% of the materials are contaminated with bacteria. The highest level of contamination was 
found at department for dialysis 45.1% and the ophthalmology department with 20%. From hospital sterilization 
area were taken 24 spores and all were negative. 
 
 
Table No. 6 - Examined swabs in Clinical Hospital Stip in 2011 
Department 
Uncontaminated  
materials % 
Contaminated  
materials % 
Gynecology dep. 77,70% 22,30% 
Surgery dep 61,20% 38,80% 
Orthopaedic dep. 64,70% 35,30% 
Anesthesiology 
dep 65,50% 34,50% 
Dep. for dialysis 83% 17% 
Pediatrics 74,30% 25,70% 
Ophthalmology 
dep. 80% 20% 
other 86,60% 13,40% 
 
Graph No. 12 - Graphic display of swabs examined in Clinical Hospital Stip in 2011 
 
In 2011 epidemiological service of the Center for Public Health Stip perform 58 hygiene-epidemiological insights in 
Clinical Hospital Stip in areas where is the greatest opportunity for emergence and spread of hospital infections.. 
During this year were examined total 587 materials. 462 of these were sterile and at 125 were found present bacteria. 
In fact 21.2% of the materials are contaminated with bacteria. The greatest percentage of contamination was found 
at surgery department 38.8% and 17%  department for dialysis. From hospital pharmacy were taken seven samples 
of distilled water. All samples were without bacterial contamination. 
5.0 Conclusions  
In relation to Article 49 of the Law on protection of the population from infectious diseases Official. Gazette No. 66 
of 01.10.2004 and the Rulebook on the criteria for the prevention and elimination of intra-hospital infections 
Official Gazette of RM No. 25 of 20.02.2008, and in order to prevent and eliminate intra-hospital infections, shorter 
hospitalization and reducing of the cost of treating inpatients, adopted a Programme for the Prevention and 
suppression of intra-hospital infections, which is led by the Clinical hospital "Stip. Intra-hospital infections represent 
a socio-economic problem. As a complication of the underlying disease, the number of hospital days, an average of 
4-57%, thus making a negative impact on the financial effects. The cost of hospital costs for additional antibiotic 
and other therapy, used to treat patients for the occurrence of hospital infections, can be increased by 3-42%, 
depending on the type of infection. Proper use of disinfectants and antiseptics generally gives a good picture of the 
functioning of the health institution. Regular audits, managing them and cooperation with the Centre for Public 
Health enables maintaining hospital permissible limits for operation. 
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